Search Results - "Swidorski, Jacob J."
-
1
A Concise Total Synthesis of (−)-Cylindricine C through a Stereoselective Intramolecular Aza-[3 + 3] Annulation Strategy
Published in Organic letters (16-02-2006)“…An enantioselective total synthesis of (−)-cylindricine C is described, featuring a diastereoselective intramolecular aza-[3 + 3] annulation strategy and an…”
Get full text
Journal Article -
2
An N-Acyliminium Cyclization Approach to a Total Synthesis of (+)-Cylindricine C
Published in Journal of organic chemistry (13-05-2005)“…Details of problems and solutions encountered during the development of an enantioselective total synthesis of (+)-cylindricine C are described here. The total…”
Get full text
Journal Article -
3
Atropisomerism Observed in Galactose-Based Monosaccharide Inhibitors of Galectin-3 Comprising 2-Methyl-4-phenyl-2,4-dihydro-3 H -1,2,4-triazole-3-thione
Published in Journal of medicinal chemistry (22-08-2024)“…Galectin-3 (Gal-3) is a carbohydrate binding protein that has been implicated in the development and progression of fibrotic diseases. Proof-of-principal…”
Get full text
Journal Article -
4
Atropisomerism Observed in Galactose-Based Monosaccharide Inhibitors of Galectin‑3 Comprising 2‑Methyl-4-phenyl-2,4-dihydro‑3H‑1,2,4-triazole-3-thione
Published in Journal of medicinal chemistry (22-08-2024)“…Galectin-3 (Gal-3) is a carbohydrate binding protein that has been implicated in the development and progression of fibrotic diseases. Proof-of-principal…”
Get full text
Journal Article -
5
Identification and Characterization of BMS-955176, a Second-Generation HIV-1 Maturation Inhibitor with Improved Potency, Antiviral Spectrum, and Gag Polymorphic Coverage
Published in Antimicrobial agents and chemotherapy (01-07-2016)“…BMS-955176 is a second-generation human immunodeficiency virus type 1 (HIV-1) maturation inhibitor (MI). A first-generation MI, bevirimat, showed clinical…”
Get full text
Journal Article -
6
The Discovery of GSK3640254, a Next-Generation Inhibitor of HIV‑1 Maturation
Published in Journal of medicinal chemistry (22-09-2022)“…GSK3640254 is an HIV-1 maturation inhibitor (MI) that exhibits significantly improved antiviral activity toward a range of clinically relevant polymorphic…”
Get full text
Journal Article -
7
Design and exploration of C-3 benzoic acid bioisosteres and alkyl replacements in the context of GSK3532795 (BMS-955176) that exhibit broad spectrum HIV-1 maturation inhibition
Published in Bioorganic & medicinal chemistry letters (15-03-2021)“…[Display omitted] GSK3532795 (formerly BMS-955176) is a second-generation HIV-1 maturation inhibitor that has shown broad spectrum antiviral activity and…”
Get full text
Journal Article -
8
The design, synthesis and structure-activity relationships associated with C28 amine-based betulinic acid derivatives as inhibitors of HIV-1 maturation
Published in Bioorganic & medicinal chemistry letters (15-05-2018)“…[Display omitted] The design and synthesis of a series of C28 amine-based betulinic acid derivatives as HIV-1 maturation inhibitors is described. This series…”
Get full text
Journal Article -
9
Discovery and exploration of monosaccharide linked dimers of galectin-3 inhibitors to target fibrosis
Published in Medicinal chemistry research (01-07-2023)“…Galectin proteins have been targets of interest in numerous therapeutic areas for some time. Galectin-3 has been identified as a target of particular interest…”
Get full text
Journal Article -
10
Inhibitors of HIV-1 attachment: The discovery and structure–activity relationships of tetrahydroisoquinolines as replacements for the piperazine benzamide in the 3-glyoxylyl 6-azaindole pharmacophore
Published in Bioorganic & medicinal chemistry letters (01-01-2016)“…[Display omitted] 6,6-Fused ring systems including tetrahydroisoquinolines and tetrahydropyrido[3,4-d]pyrimidines have been explored as possible replacements…”
Get full text
Journal Article -
11
Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1) Attachment. 12. Structure–Activity Relationships Associated with 4‑Fluoro-6-azaindole Derivatives Leading to the Identification of 1‑(4-Benzoylpiperazin-1-yl)-2-(4-fluoro-7-[1,2,3]triazol-1-yl‑1H‑pyrrolo[2,3‑c]pyridin-3-yl)ethane-1,2-dione (BMS-585248)
Published in Journal of medicinal chemistry (28-02-2013)“…A series of highly potent HIV-1 attachment inhibitors with 4-fluoro-6-azaindole core heterocycles that target the viral envelope protein gp120 has been…”
Get full text
Journal Article -
12
Inhibitors of HIV-1 maturation: Development of structure–activity relationship for C-28 amides based on C-3 benzoic acid-modified triterpenoids
Published in Bioorganic & medicinal chemistry letters (15-04-2016)“…[Display omitted] We have recently reported on the discovery of a C-3 benzoic acid (1) as a suitable replacement for the dimethyl succinate side chain of…”
Get full text
Journal Article -
13
C-3 benzoic acid derivatives of C-3 deoxybetulinic acid and deoxybetulin as HIV-1 maturation inhibitors
Published in Bioorganic & medicinal chemistry (15-04-2016)“…[Display omitted] A series of C-3 phenyl- and heterocycle-substituted derivatives of C-3 deoxybetulinic acid and C-3 deoxybetulin was designed and synthesized…”
Get full text
Journal Article -
14
Microbial transformations of betulinic and betulonic acids
Published in Journal of molecular catalysis. B, Enzymatic (01-07-2015)“…•Enzymatic oxidations of betulinic and betulonic acids.•Biotransformations with two bacteria and two fungi were studied.•Several di-, tri-, tetrahydroxy and…”
Get full text
Journal Article -
15
Discovery of BMS-955176, a Second Generation HIV‑1 Maturation Inhibitor with Broad Spectrum Antiviral Activity
Published in ACS medicinal chemistry letters (09-06-2016)“…HIV-1 maturation inhibition (MI) has been clinically validated as an approach to the control of HIV-1 infection. However, identifying an MI with both broad…”
Get full text
Journal Article -
16
Design, Synthesis, and SAR of C-3 Benzoic Acid, C-17 Triterpenoid Derivatives. Identification of the HIV-1 Maturation Inhibitor 4-((1 R,3a S,5a R,5b R,7a R,11a S,11b R,13a R,13b R)-3a-((2-(1,1-Dioxidothiomorpholino)ethyl)amino)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1 H-cyclopenta[ a]chrysen-9-yl)benzoic Acid (GSK3532795, BMS-955176)
Published in Journal of medicinal chemistry (23-08-2018)“…GSK3532795, formerly known as BMS-955176 (1), is a potent, orally active, second-generation HIV-1 maturation inhibitor (MI) that advanced through phase IIb…”
Get full text
Journal Article -
17
A Lewis Acid-Catalyzed Formal [3 + 3] Cycloaddition of α,β-Unsaturated Aldehydes with 4-Hydroxy-2-Pyrone, Diketones, and Vinylogous Esters
Published in Organic letters (19-01-2006)“…A Lewis acid-catalyzed formal cycloaddition of α,β-unsaturated aldehydes with 6-methyl-4-hydroxy-2-pyrone, 1,3-diketones, and vinylogous silyl esters is…”
Get full text
Journal Article -
18
An Efficient Assembly of Heterobenzazepine Ring Systems Utilizing an Intramolecular Palladium-Catalyzed Cycloamination
Published in Journal of organic chemistry (24-01-2003)“…Azaheterocyclic compounds are interesting and medicinally relevant targets. Herein we disclose an improved synthesis into the oxazepine and thiazepine ring…”
Get full text
Journal Article -
19
Design, Synthesis, and SAR of C‑3 Benzoic Acid, C‑17 Triterpenoid Derivatives. Identification of the HIV‑1 Maturation Inhibitor 4‑((1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)‑3a-((2-(1,1-Dioxidothiomorpholino)ethyl)amino)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro‑1H‑cyclopenta[a]chrysen-9-yl)benzoic Acid (GSK3532795, BMS-955176)
Published in Journal of medicinal chemistry (23-08-2018)“…GSK3532795, formerly known as BMS-955176 (1), is a potent, orally active, second-generation HIV-1 maturation inhibitor (MI) that advanced through phase IIb…”
Get full text
Journal Article -
20
Invention of VH-937, a Potent HIV‑1 Maturation Inhibitor with the Potential for Infrequent Oral Dosing in Humans
Published in ACS medicinal chemistry letters (14-11-2024)“…Newer generation HIV-1 maturation inhibitors have proven to be viable antiretroviral agents in the clinic. VH3739937, (VH-937, 24) is an advanced HIV-1…”
Get full text
Journal Article